<?xml version="1.0" encoding="utf-8" standalone="no"?>
<!--
  ~ Software License, Version 1.0 Copyright 2010 SRA International, Inc.
  ~ Copyright Notice.  The software subject to this notice and license includes both human
  ~ readable source code form and machine readable, binary, object code form (the "caBIG
  ~ Software").
  ~
  ~ Please refer to the complete License text for full details at the root of the project.
  -->

<TCGA_BCR xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
          xsi:noNamespaceSchemaLocation="intgen.org_TCGA_ver2.xsdorg_TCGA_ver2.xsd">
    <PATIENT>
        <TUMORTISSUESITE cde="2673795">GBM</TUMORTISSUESITE>
        <GENDER cde="62"/>
        <VITALSTATUS cde="2190384"/>
        <DATEOFBIRTH cde="2673798"/>
        <DATEOFDEATH cde="2673799"/>
        <DATEOFLASTFOLLOWUP cde="2673800"/>
        <RACE cde="106"/>
        <SMOKINGHISTORY cde="2673804"/>
        <ALCOHOLCONSUMPTION cde="2673801"/>
        <ENVIRONMENTALEXPOSURE cde="2673802"/>
        <INFORMEDCONSENTACQUIRED cde="2673803">NO</INFORMEDCONSENTACQUIRED>
        <TNMCLINICALSTAGEGROUPING cde=""/>
        <TNMCLINICALTUMORSTATUS cde="2673763"/>
        <TNMCLINICALLYMPHNODESTATUS cde="2451589"/>
        <TNMCLINICALMETASTATICSTATUS cde="2451585"/>
        <BCRSITEID/>
        <BCRPATIENTBARCODE cde="2673794">TCGA-06-0119</BCRPATIENTBARCODE>
        <REVISION cde="">2</REVISION>
        <SAMPLES>
            <SAMPLE>
                <SAMPLETYPE cde="2673865">TUMOR</SAMPLETYPE>
                <LONGESTDIMENSION cde="2673866">1.0</LONGESTDIMENSION>
                <INTERMEDIATEDIMENSION cde="2673867">0.0010000000474974513</INTERMEDIATEDIMENSION>
                <SHORTESTDIMENSION cde="2673868">0.30000001192092896</SHORTESTDIMENSION>
                <INITIALWEIGHT cde="2673869">1000.0</INITIALWEIGHT>
                <CURRENTWEIGHT cde="2673870">19.0</CURRENTWEIGHT>
                <FREEZINGMETHOD cde="2673871"/>
                <OCTEMBEDDED cde="2673872">NO</OCTEMBEDDED>
                <DATEOFCOLLECTION cde="64191">1999-09-09 00:00:00.0</DATEOFCOLLECTION>
                <TIMEBETWEENCLAMPINGANDFREEZING cde="2673873"/>
                <TIMEBETWEENEXCISIONANDFREEZING cde="2673874"/>
                <BCRSAMPLEBARCODE cde="2673864">TCGA-06-0119-01A</BCRSAMPLEBARCODE>
                <PORTIONS>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-04-25 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">181.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-01</BCRPORTIONBARCODE>
                        <ANALYTES/>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">TOP</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">1-19</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">70-79</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">70-79</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">11-15</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">NO</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">NO</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">LOW</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">1-19</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">20-29</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">70-79</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">21-25</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-01-BS1</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">NO</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">NO</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">MEDIUM</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-05-29 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">100.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-02</BCRPORTIONBARCODE>
                        <ANALYTES>
                            <ANALYTE>
                                <TYPE cde="2673836">DNA</TYPE>
                                <CONCENTRATION cde="2673837">0.13430480659008026</CONCENTRATION>
                                <AMOUNT cde="2673838">110.23318481445312</AMOUNT>
                                <A260A280RATIO cde="2673841">1.8980274200439453</A260A280RATIO>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-01A-02D</BCRANALYTEBARCODE>
                                <ALIQUOTS/>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778">nucleic_acid_extraction
                                        </EXPERIMENTALPROTOCOLTYPE>
                                        <PROTOCOLNAME cde="2423104">DNA/RNA Extraction with Allprep Kit</PROTOCOLNAME>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779">03.002v2-DNA RNA Extraction with Allprep Kit.doc
                                        </PROTOCOLFILENAME>
                                    </PROTOCOL>
                                </PROTOCOLS>
                                <DNA>
                                    <NORMALTUMORGENOTYPEMATCH cde="2673757">NO</NORMALTUMORGENOTYPEMATCH>
                                    <PCRAMPLIFICATIONSUCCESSFUL cde="2673758">YES</PCRAMPLIFICATIONSUCCESSFUL>
                                </DNA>
                            </ANALYTE>
                        </ANALYTES>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">1-19</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">20-29</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">70-79</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">21-25</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-01-BS1</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">NO</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">NO</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">MEDIUM</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">90-100</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-02-BS2</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-05-29 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">100.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-03</BCRPORTIONBARCODE>
                        <ANALYTES>
                            <ANALYTE>
                                <TYPE cde="2673836">DNA</TYPE>
                                <CONCENTRATION cde="2673837">0.13924540579319</CONCENTRATION>
                                <AMOUNT cde="2673838">106.67570495605469</AMOUNT>
                                <A260A280RATIO cde="2673841">1.890965461730957</A260A280RATIO>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-01A-03D</BCRANALYTEBARCODE>
                                <ALIQUOTS/>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778">nucleic_acid_extraction
                                        </EXPERIMENTALPROTOCOLTYPE>
                                        <PROTOCOLNAME cde="2423104">DNA/RNA Extraction with Allprep Kit</PROTOCOLNAME>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779">03.002v2-DNA RNA Extraction with Allprep Kit.doc
                                        </PROTOCOLFILENAME>
                                    </PROTOCOL>
                                </PROTOCOLS>
                                <DNA>
                                    <NORMALTUMORGENOTYPEMATCH cde="2673757">NO</NORMALTUMORGENOTYPEMATCH>
                                    <PCRAMPLIFICATIONSUCCESSFUL cde="2673758">YES</PCRAMPLIFICATIONSUCCESSFUL>
                                </DNA>
                            </ANALYTE>
                        </ANALYTES>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">90-100</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-02-BS2</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">90-100</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-03-BS3</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-05-29 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">100.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-04</BCRPORTIONBARCODE>
                        <ANALYTES/>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">90-100</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-03-BS3</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">0</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-04-BS4</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-05-29 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">100.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-05</BCRPORTIONBARCODE>
                        <ANALYTES/>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">0</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-04-BS4</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">0</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-05-BS5</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-05-29 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">100.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-06</BCRPORTIONBARCODE>
                        <ANALYTES>
                            <ANALYTE>
                                <TYPE cde="2673836">DNA</TYPE>
                                <CONCENTRATION cde="2673837">0.19120639562606812</CONCENTRATION>
                                <AMOUNT cde="2673838">110.16085815429688</AMOUNT>
                                <A260A280RATIO cde="2673841">1.9004257917404175</A260A280RATIO>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-01A-06D</BCRANALYTEBARCODE>
                                <ALIQUOTS/>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778">nucleic_acid_extraction
                                        </EXPERIMENTALPROTOCOLTYPE>
                                        <PROTOCOLNAME cde="2423104">DNA/RNA Extraction with Allprep Kit</PROTOCOLNAME>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779">03.002v2-DNA RNA Extraction with Allprep Kit.doc
                                        </PROTOCOLFILENAME>
                                    </PROTOCOL>
                                </PROTOCOLS>
                                <DNA>
                                    <NORMALTUMORGENOTYPEMATCH cde="2673757">NO</NORMALTUMORGENOTYPEMATCH>
                                    <PCRAMPLIFICATIONSUCCESSFUL cde="2673758">YES</PCRAMPLIFICATIONSUCCESSFUL>
                                </DNA>
                            </ANALYTE>
                        </ANALYTES>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">0</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-05-BS5</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">0</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-06-BS6</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-05-29 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">100.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-07</BCRPORTIONBARCODE>
                        <ANALYTES/>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">0</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">0</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">0</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-06-BS6</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">UNKNOWN</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">UNKNOWN</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">20-29</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">85-89</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">80-89</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">15</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">96-100</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-07-BS7</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">NO</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">MEDIUM</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-05-29 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">100.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-08</BCRPORTIONBARCODE>
                        <ANALYTES>
                            <ANALYTE>
                                <TYPE cde="2673836">DNA</TYPE>
                                <CONCENTRATION cde="2673837">0.15795573592185974</CONCENTRATION>
                                <AMOUNT cde="2673838">0.0</AMOUNT>
                                <A260A280RATIO cde="2673841">1.89423668384552</A260A280RATIO>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-01A-08D</BCRANALYTEBARCODE>
                                <ALIQUOTS>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">13.300000190734863</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">

                                            2007-06-28 00:00:00.0

                                        </SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">

                                            TCGA-06-0119-01A-08D-0214-01

                                        </BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">33.29999923706055</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-01A-08D-215-04</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">20.0</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-01A-08D-216-06</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">33.29999923706055</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-01A-08D-217-02</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">33.29999923706055</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-01A-08D-218-05</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                </ALIQUOTS>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778">nucleic_acid_extraction
                                        </EXPERIMENTALPROTOCOLTYPE>
                                        <PROTOCOLNAME cde="2423104">DNA/RNA Extraction with Allprep Kit</PROTOCOLNAME>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779">
                                            03.002v2-DNA%20RNA%20Extraction%20with%20Allprep%20Kit.doc
                                        </PROTOCOLFILENAME>
                                    </PROTOCOL>
                                </PROTOCOLS>
                                <DNA>
                                    <NORMALTUMORGENOTYPEMATCH cde="2673757">YES</NORMALTUMORGENOTYPEMATCH>
                                    <PCRAMPLIFICATIONSUCCESSFUL cde="2673758">YES</PCRAMPLIFICATIONSUCCESSFUL>
                                </DNA>
                            </ANALYTE>
                            <ANALYTE>
                                <TYPE cde="2673836">WGA</TYPE>
                                <CONCENTRATION cde="2673837">0.5</CONCENTRATION>
                                <AMOUNT cde="2673838">1483.1026611328125</AMOUNT>
                                <A260A280RATIO cde="2673841"/>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-01A-08W</BCRANALYTEBARCODE>
                                <ALIQUOTS/>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778"/>
                                        <PROTOCOLNAME cde="2423104"/>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779"/>
                                    </PROTOCOL>
                                </PROTOCOLS>
                            </ANALYTE>
                            <ANALYTE>
                                <TYPE cde="2673836">RNA</TYPE>
                                <CONCENTRATION cde="2673837">0.033131420612335205</CONCENTRATION>
                                <AMOUNT cde="2673838">0.5</AMOUNT>
                                <A260A280RATIO cde="2673841">1.7426198720932007</A260A280RATIO>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-01A-08R</BCRANALYTEBARCODE>
                                <ALIQUOTS>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">13.300000190734863</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-01A-08R-213-07</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                </ALIQUOTS>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778">nucleic_acid_extraction
                                        </EXPERIMENTALPROTOCOLTYPE>
                                        <PROTOCOLNAME cde="2423104">DNA/RNA Extraction with Allprep Kit</PROTOCOLNAME>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779">
                                            03.002v2-DNA%20RNA%20Extraction%20with%20Allprep%20Kit.doc
                                        </PROTOCOLFILENAME>
                                    </PROTOCOL>
                                </PROTOCOLS>
                                <RNA>
                                    <RATIO28S18S cde="2673782">2.5</RATIO28S18S>
                                    <RINVALUE cde="2673783">5.8</RINVALUE>
                                </RNA>
                            </ANALYTE>
                            <ANALYTE>
                                <TYPE cde="2673836">RNA</TYPE>
                                <CONCENTRATION cde="2673837">0.009999999776482582</CONCENTRATION>
                                <AMOUNT cde="2673838">18.0</AMOUNT>
                                <A260A280RATIO cde="2673841">0.0</A260A280RATIO>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-01A-08T</BCRANALYTEBARCODE>
                                <ALIQUOTS/>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778">nucleic_acid_extraction
                                        </EXPERIMENTALPROTOCOLTYPE>
                                        <PROTOCOLNAME cde="2423104">DNA/RNA Extraction with Allprep Kit</PROTOCOLNAME>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779">
                                            03.002v2-DNA%20RNA%20Extraction%20with%20Allprep%20Kit.doc
                                        </PROTOCOLFILENAME>
                                    </PROTOCOL>
                                </PROTOCOLS>
                                <RNA>
                                    <RATIO28S18S cde="2673782">0.0</RATIO28S18S>
                                    <RINVALUE cde="2673783"/>
                                </RNA>
                            </ANALYTE>
                        </ANALYTES>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">20-29</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">85-89</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">80-89</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">15</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">96-100</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-07-BS7</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">UNKNOWN</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">NO</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">MEDIUM</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">20-29</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">70-79</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">70-79</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">1-5</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">25</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">16-20</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">76-80</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-08-BS8</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">YES</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">YES</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">MEDIUM</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-05-29 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">100.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01A-09</BCRPORTIONBARCODE>
                        <ANALYTES/>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">0.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">20-29</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">70-79</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">70-79</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">1-5</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">25</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">16-20</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">76-80</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-08-BS8</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">YES</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">YES</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">MEDIUM</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">1.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">1-19</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">95-100</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">90-100</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">0</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01A-09-BS9</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">YES</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">NO</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">HIGH</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                </PORTIONS>
                <TUMORPATHOLOGY>
                    <PRIMARYORMETASTATICSTATUS cde="2673765">NOT SPECIFIED</PRIMARYORMETASTATICSTATUS>
                    <MARGINSINVOLVED cde="2608099"/>
                    <VENOUSINVASION cde="2673766"/>
                    <LYMPHATICINVASION cde="2673767"/>
                    <NUMBERREGIONALLYMPHNODESEXAM cde="2673768"/>
                    <NUMBERREGIONALLYMPHNODESPOS cde="2673770"/>
                    <VERIFICATIONBYBCR cde="2673771">NO</VERIFICATIONBYBCR>
                    <TYPE>
                        <GBMPATHOLOGY>
                            <HISTOLOGICTYPE cde="2673856"/>
                            <HISTOLOGICNUCLEARGRADE cde="2673857"/>
                            <TUMORSAMPLEANATOMICLOCATION cde="2673858">NOT SPECIFIED</TUMORSAMPLEANATOMICLOCATION>
                            <GEMISTOCYTESPRESENT cde="2673859"/>
                            <OLIGODENDROGLIALCOMPONENT cde="2673860"/>
                            <LEPTOMENINGEALINVOLEMENT cde="2673861"/>
                            <GFAP_POSITIVE cde="2673862"/>
                            <MIB1_POSITIVE cde="2673863"/>
                        </GBMPATHOLOGY>
                    </TYPE>
                </TUMORPATHOLOGY>
            </SAMPLE>
            <SAMPLE>
                <SAMPLETYPE cde="2673865">TUMOR</SAMPLETYPE>
                <LONGESTDIMENSION cde="2673866">0.8999999761581421</LONGESTDIMENSION>
                <INTERMEDIATEDIMENSION cde="2673867">1.100000023841858</INTERMEDIATEDIMENSION>
                <SHORTESTDIMENSION cde="2673868">0.8999999761581421</SHORTESTDIMENSION>
                <INITIALWEIGHT cde="2673869">1000.0</INITIALWEIGHT>
                <CURRENTWEIGHT cde="2673870">862.0</CURRENTWEIGHT>
                <FREEZINGMETHOD cde="2673871"/>
                <OCTEMBEDDED cde="2673872">NO</OCTEMBEDDED>
                <DATEOFCOLLECTION cde="64191">1999-09-09 00:00:00.0</DATEOFCOLLECTION>
                <TIMEBETWEENCLAMPINGANDFREEZING cde="2673873"/>
                <TIMEBETWEENEXCISIONANDFREEZING cde="2673874"/>
                <BCRSAMPLEBARCODE cde="2673864">TCGA-06-0119-01B</BCRSAMPLEBARCODE>
                <PORTIONS>
                    <PORTION>
                        <DATECREATED cde="2673760">2007-06-25 00:00:00.0</DATECREATED>
                        <WEIGHT cde="2673761">138.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-01B-01</BCRPORTIONBARCODE>
                        <ANALYTES/>
                        <SLIDES>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">TOP</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">4.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">20-29</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">80-84</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">20-29</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">46-50</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01B-TS1</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">YES</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">YES</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">LOW</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                            <SLIDE>
                                <SECTIONLOCATION cde="2673929">BOTTOM</SECTIONLOCATION>
                                <NUMBERPROLIFERATINGCELLS cde="2673930">4.0</NUMBERPROLIFERATINGCELLS>
                                <PERCENTTUMORCELLS cde="2673931">20-29</PERCENTTUMORCELLS>
                                <PERCENTTUMORNUCLEI cde="2673932">70-79</PERCENTTUMORNUCLEI>
                                <PERCENTNORMALCELLS cde="2673933">0</PERCENTNORMALCELLS>
                                <PERCENTNECROSIS cde="2673934">6-10</PERCENTNECROSIS>
                                <PERCENTSTROMALCELLS cde="2673935">61-70</PERCENTSTROMALCELLS>
                                <PERCENTINFLAMINFILTRATION cde="2673941">0</PERCENTINFLAMINFILTRATION>
                                <PERCENTLYMPHOCYTEINFILTRATION cde="2673937">0</PERCENTLYMPHOCYTEINFILTRATION>
                                <PERCENTMONOCYTEINFILTRATION cde="2673938">0</PERCENTMONOCYTEINFILTRATION>
                                <PERCENTGRANULOCYTEINFILTRATION cde="2673939">0</PERCENTGRANULOCYTEINFILTRATION>
                                <PERCENTNEUTROPHILINFILTRATION cde="2673940">0</PERCENTNEUTROPHILINFILTRATION>
                                <PERCENTEOSINOPHILINFILTRATION cde="2673941">0</PERCENTEOSINOPHILINFILTRATION>
                                <BCRSLIDEBARCODE cde="2673821">TCGA-06-0119-01B-01-BS1</BCRSLIDEBARCODE>
                                <TYPE>
                                    <GBMSLIDE>
                                        <ENDOTHELIALPROLIFERATION cde="2673813">YES</ENDOTHELIALPROLIFERATION>
                                        <NUCLEARPLEOMORPHISM cde="2673814"/>
                                        <PALISADINGNECROSIS cde="2673815">YES</PALISADINGNECROSIS>
                                        <CELLULARITY cde="2673816">LOW</CELLULARITY>
                                    </GBMSLIDE>
                                </TYPE>
                            </SLIDE>
                        </SLIDES>
                    </PORTION>
                </PORTIONS>
                <TUMORPATHOLOGY>
                    <PRIMARYORMETASTATICSTATUS cde="2673765">NOT SPECIFIED</PRIMARYORMETASTATICSTATUS>
                    <MARGINSINVOLVED cde="2608099"/>
                    <VENOUSINVASION cde="2673766"/>
                    <LYMPHATICINVASION cde="2673767"/>
                    <NUMBERREGIONALLYMPHNODESEXAM cde="2673768"/>
                    <NUMBERREGIONALLYMPHNODESPOS cde="2673770"/>
                    <VERIFICATIONBYBCR cde="2673771">NO</VERIFICATIONBYBCR>
                    <TYPE>
                        <GBMPATHOLOGY>
                            <HISTOLOGICTYPE cde="2673856"/>
                            <HISTOLOGICNUCLEARGRADE cde="2673857"/>
                            <TUMORSAMPLEANATOMICLOCATION cde="2673858">NOT SPECIFIED</TUMORSAMPLEANATOMICLOCATION>
                            <GEMISTOCYTESPRESENT cde="2673859"/>
                            <OLIGODENDROGLIALCOMPONENT cde="2673860"/>
                            <LEPTOMENINGEALINVOLEMENT cde="2673861"/>
                            <GFAP_POSITIVE cde="2673862"/>
                            <MIB1_POSITIVE cde="2673863"/>
                        </GBMPATHOLOGY>
                    </TYPE>
                </TUMORPATHOLOGY>
            </SAMPLE>
            <SAMPLE>
                <SAMPLETYPE cde="2673865">OTHER NORMAL</SAMPLETYPE>
                <LONGESTDIMENSION cde="2673866"/>
                <INTERMEDIATEDIMENSION cde="2673867"/>
                <SHORTESTDIMENSION cde="2673868"/>
                <INITIALWEIGHT cde="2673869">0.5</INITIALWEIGHT>
                <CURRENTWEIGHT cde="2673870">0.0</CURRENTWEIGHT>
                <FREEZINGMETHOD cde="2673871"/>
                <OCTEMBEDDED cde="2673872">NO</OCTEMBEDDED>
                <DATEOFCOLLECTION cde="64191"/>
                <TIMEBETWEENCLAMPINGANDFREEZING cde="2673873"/>
                <TIMEBETWEENEXCISIONANDFREEZING cde="2673874"/>
                <BCRSAMPLEBARCODE cde="2673864">TCGA-06-0119-10A</BCRSAMPLEBARCODE>
                <PORTIONS>
                    <PORTION>
                        <DATECREATED cde="2673760"/>
                        <WEIGHT cde="2673761">0.0</WEIGHT>
                        <BCRPORTIONBARCODE cde="2673759">TCGA-06-0119-10A-01</BCRPORTIONBARCODE>
                        <ANALYTES>
                            <ANALYTE>
                                <TYPE cde="2673836">DNA</TYPE>
                                <CONCENTRATION cde="2673837">0.1453496813774109</CONCENTRATION>
                                <AMOUNT cde="2673838">0.21708989143371582</AMOUNT>
                                <A260A280RATIO cde="2673841">1.951702356338501</A260A280RATIO>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-10A-01D</BCRANALYTEBARCODE>
                                <ALIQUOTS>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">13.300000190734863</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-10A-01D-214-01</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">33.29999923706055</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-10A-01D-215-04</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">20.0</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-10A-01D-216-06</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                    <ALIQUOT>
                                        <AMOUNT cde="2613227">33.29999923706055</AMOUNT>
                                        <SHIPPINGDATE cde="2673781">2007-06-28 00:00:00.0</SHIPPINGDATE>
                                        <BCRALIQUOTBARCODE cde="2673780">TCGA-06-0119-10A-01D-217-02</BCRALIQUOTBARCODE>
                                        <CONCENTRATION cde="2613228">0.15000000596046448</CONCENTRATION>
                                    </ALIQUOT>
                                </ALIQUOTS>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778">nucleic_acid_extraction
                                        </EXPERIMENTALPROTOCOLTYPE>
                                        <PROTOCOLNAME cde="2423104">Extraction of DNA from Blood</PROTOCOLNAME>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779">
                                            03.002v2-DNA%20RNA%20Extraction%20with%20Allprep%20Kit.doc
                                        </PROTOCOLFILENAME>
                                    </PROTOCOL>
                                </PROTOCOLS>
                                <DNA>
                                    <NORMALTUMORGENOTYPEMATCH cde="2673757">YES</NORMALTUMORGENOTYPEMATCH>
                                    <PCRAMPLIFICATIONSUCCESSFUL cde="2673758">YES</PCRAMPLIFICATIONSUCCESSFUL>
                                </DNA>
                            </ANALYTE>
                            <ANALYTE>
                                <TYPE cde="2673836">WGA</TYPE>
                                <CONCENTRATION cde="2673837">0.5</CONCENTRATION>
                                <AMOUNT cde="2673838">1307.9801025390625</AMOUNT>
                                <A260A280RATIO cde="2673841"/>
                                <GELIMAGEFILE cde="2673842">
                                    https://atlas.intgen.org/bcr-data/Molecular%20Analyte%20Data/
                                </GELIMAGEFILE>
                                <WELLNUMBER cde="2673843"/>
                                <BCRANALYTEBARCODE cde="2673835">TCGA-06-0119-10A-01W</BCRANALYTEBARCODE>
                                <ALIQUOTS/>
                                <PROTOCOLS>
                                    <PROTOCOL>
                                        <EXPERIMENTALPROTOCOLTYPE cde="2673778"/>
                                        <PROTOCOLNAME cde="2423104"/>
                                        <PROTOCOLTEXT cde=""/>
                                        <PROTOCOLFILENAME cde="2673779"/>
                                    </PROTOCOL>
                                </PROTOCOLS>
                            </ANALYTE>
                        </ANALYTES>
                        <SLIDES/>
                    </PORTION>
                </PORTIONS>
                <TUMORPATHOLOGY>
                    <PRIMARYORMETASTATICSTATUS cde="2673765">NON-MALIGNANT</PRIMARYORMETASTATICSTATUS>
                    <MARGINSINVOLVED cde="2608099"/>
                    <VENOUSINVASION cde="2673766"/>
                    <LYMPHATICINVASION cde="2673767"/>
                    <NUMBERREGIONALLYMPHNODESEXAM cde="2673768"/>
                    <NUMBERREGIONALLYMPHNODESPOS cde="2673770"/>
                    <VERIFICATIONBYBCR cde="2673771">NO</VERIFICATIONBYBCR>
                    <TYPE>
                        <GBMPATHOLOGY>
                            <HISTOLOGICTYPE cde="2673856">NO HISTOLOGY AVAILABLE</HISTOLOGICTYPE>
                            <HISTOLOGICNUCLEARGRADE cde="2673857"/>
                            <TUMORSAMPLEANATOMICLOCATION cde="2673858">BLOOD</TUMORSAMPLEANATOMICLOCATION>
                            <GEMISTOCYTESPRESENT cde="2673859"/>
                            <OLIGODENDROGLIALCOMPONENT cde="2673860"/>
                            <LEPTOMENINGEALINVOLEMENT cde="2673861"/>
                            <GFAP_POSITIVE cde="2673862"/>
                            <MIB1_POSITIVE cde="2673863"/>
                        </GBMPATHOLOGY>
                    </TYPE>
                </TUMORPATHOLOGY>
            </SAMPLE>
        </SAMPLES>
        <DRUGS/>
        <RADIATIONS/>
        <EXAMINATIONS/>
        <SURGERIES/>
    </PATIENT>
</TCGA_BCR>